Blog
RSS FeedPosted by Michael Wonder on 27 Sep 2019
With Brexit looming, what does the future hold for UK biosimilars?
26 September 2019 - If and when the United Kingdom leaves the European Union, the Medicines and Healthcare Products Regulatory Agency ...
Posted by Michael Wonder on 25 Sep 2019
Labour Party takes aim at pharma, calls attention to Orkambi row
25 September 2019 - Proposal to introduce compulsory licensing faces industry criticism. ...
Posted by Michael Wonder on 25 Sep 2019
Children with cancer are missing out on precision medicine, study finds
24 September 2019 - Only a small number of children with solid tumour cancers are able to access targeted precision ...
Posted by Michael Wonder on 23 Sep 2019
UK families in buyers club fly to Argentina for cystic fibrosis drugs
23 September 2019 - Six British people have travelled to Argentina to get supplies of two potentially life-saving medicines for ...
Posted by Michael Wonder on 18 Sep 2019
'A child's health should not be a postcode lottery': anger of cystic fibrosis sufferers forced to pay £20,000 for drug abroad
17 September 2019 - Patients have formed a buyers' club to source a version of Orkambi after the drug's manufacturer and ...
Posted by Michael Wonder on 17 Sep 2019
News NHS England explores funding options for cystic fibrosis drug
17 September 2019 - NHS England is “committed to exploring and developing alternative routes” to enable people with cystic fibrosis ...
Posted by Michael Wonder on 12 Sep 2019
Batten disease treatment: parents win battle ahead of court date
11 September 2019 - Families of children with a rare degenerative disease have won their fight for funding for NHS ...
Posted by Michael Wonder on 11 Sep 2019
Children with rare inherited condition to benefit from drug through managed access agreement
11 September 2019 - It is estimated that in the UK there are around 30 to 50 children living with the ...
Posted by Michael Wonder on 28 Aug 2019
Batten disease treatment: parents can take fight to High Court
28 August 2019 - Two sets of parents of children with a rare degenerative disease can take a fight for ...
Posted by Michael Wonder on 20 Aug 2019
NICE’s track record in cancer drugs: the impact of the CDF and interim funding
20 August 2019 - Cancer drugs and the decisions made by the UK’s NICE have been subject to much scrutiny ...
Posted by Michael Wonder on 12 Aug 2019
Drug maker 'will make $21 billion from treating cystic fibrosis'
12 August 2019 - Vertex is accused of raking in vast profits while making Orkambi unaffordable to NHS. ...
Posted by Michael Wonder on 11 Aug 2019
Watchdog declines to back NHS cannabis treatment for epilepsy
8 August 2019 - NICE draft guidance and NHS England review highlight need for more research on cannabis-based medicinal products.
...
Posted by Michael Wonder on 10 Jul 2019
Amazon’s Alexa to offer NHS health care advice
10 July 2019 - The UK Government has announced that the NHS has plans to collaborate with Amazon to provide ...
Posted by Michael Wonder on 09 Jul 2019
'Amazing' gene-silencing drugs reach NHS
9 July 2019 - A new form of medicine called "gene-silencing" has been approved for use by the NHS in ...
Posted by Michael Wonder on 08 Jul 2019
Cystic fibrosis scandal: Drugs boss tells boy, 9, he wants NHS deal to save lives
8 July 2019 - The millionaire boss of a US drugs firm has penned a personal letter to a boy with ...